Automatically computed rating scales from MRI for patients with cognitive disorders

European Radiology
Juha KoikkalainenAlzheimer’s Disease Neuroimaging Initiative

Abstract

The aims of this study were to examine whether visual MRI rating scales used in diagnostics of cognitive disorders can be estimated computationally and to compare the visual rating scales with their computed counterparts in differential diagnostics. A set of volumetry and voxel-based morphometry imaging biomarkers was extracted from T1-weighted and FLAIR images. A regression model was developed for estimating visual rating scale values from a combination of imaging biomarkers. We studied three visual rating scales: medial temporal lobe atrophy (MTA), global cortical atrophy (GCA), and white matter hyperintensities (WMHs) measured by the Fazekas scale. Images and visual ratings from the Amsterdam Dementia Cohort (ADC) (N = 513) were used to develop the models and cross-validate them. The PredictND (N = 672) and ADNI (N = 752) cohorts were used for independent validation to test generalizability. The correlation coefficients between visual and computed rating scale values were 0.83/0.78 (MTA-left), 0.83/0.79 (MTA-right), 0.64/0.64 (GCA), and 0.76/0.75 (Fazekas) in ADC/PredictND cohorts. When performance in differential diagnostics was studied for the main types of dementia, the highest balanced accuracy, 0.75-0.86, was observed f...Continue Reading

References

Jul 1, 1992·Statistics in Medicine·T J Cole, P J Green
Aug 1, 1987·AJR. American Journal of Roentgenology·F FazekasR A Zimmerman
Jun 22, 2000·NeuroImage·J Ashburner, K J Friston
Jul 10, 2003·Lancet Neurology·John T O'BrienSteven T DeKosky
Aug 25, 2004·Journal of Internal Medicine·R C Petersen
Apr 26, 2005·Aging Clinical and Experimental Research·Lorena BrescianiGiovanni B Frisoni
Nov 25, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·L A van de PolP Scheltens
Jan 28, 2006·Stroke; a Journal of Cerebral Circulation·Elisabeth C W van StraatenUNKNOWN LADIS Group
Oct 28, 2009·NeuroImage·Jyrki Mp LötjönenUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 2, 2011·European Radiology·Esther L G E KoedamMike P Wattjes
Aug 4, 2011·Brain : a Journal of Neurology·Katya RascovskyBruce L Miller
Jul 23, 2013·Lancet Neurology·Joanna M WardlawUNKNOWN STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1)
Mar 13, 2014·Journal of Alzheimer's Disease : JAD·Wiesje M van der FlierPhilip Scheltens
Mar 5, 2016·Brain : a Journal of Neurology·Lorna HarperJonathan M Schott
Apr 23, 2016·NeuroImage. Clinical·Juha KoikkalainenJyrki Lötjönen
Mar 21, 2017·Neurobiology of Aging·Mara Ten KateUNKNOWN Geneva Task Force for the Roadmap of Alzheimer's Biomarkers
Oct 16, 2018·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Marie BruunWiesje M van der Flier

❮ Previous
Next ❯

Citations

Sep 29, 2019·Journal of Alzheimer's Disease : JAD·Sini ToppalaJuha O Rinne
Dec 18, 2019·Neuro-degenerative Diseases·Sven HallerPanteleimon Giannakopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.